-
Ligand to Participate in March Investor Conferences
03 Mar 2025 12:00 GMT
… 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … or Barclays representative. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company … world’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, …
-
The Influence of the AgNPs Ligand on the Antiviral Activity Against HSV-2
04 Mar 2025 12:33 GMT
… of medroxyprogesterone (Depo-Provera; Pfizer, Puurs, Belgium) in … heparin-mimic compound (MUS-ligand) which ensures the electrostatic … of candidate antiviral microbicides. Pharmacol Ther. 2009;123(3 … stabilization of the viruses. Pharmaceutic. 2021;13(8):1182 …
-
Ligand Reports Fourth Quarter and Full Year 2024 Financial Results
27 Feb 2025 12:00 GMT
… available at www.ligand.com. About Ligand Pharmaceuticals Ligand is a … ’s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, … 315-6072
[Tables Follow]
LIGAND PHARMACEUTICALS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF …
-
Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences
25 Feb 2025 12:00 GMT
… , 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … at castlecreekbio.com. About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences, and …
-
Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
13 Feb 2025 12:17 GMT
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … call are available here.
About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … biopharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences, and Baxter …
-
Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)
10 Feb 2025 22:27 GMT
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, … -1) or programmed death-ligand 1 (PD-L1) inhibitor … and regulations, relating to pharmaceutical markets, (ii) currency … third parties. Information about pharmaceutical products (including products …
-
Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
06 Feb 2025 12:14 GMT
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today … their Oppenheimer representative.
About Ligand Pharmaceuticals
Ligand is a biopharmaceutical company enabling … biopharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences, and …
-
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
04 Feb 2025 12:00 GMT
… where she interned at Pfizer. “I am grateful … monoclonal antibody targeting CD40-ligand (CD40L or CD154) … competition. As with any pharmaceutical under development, there are … Contact Jessica Morris
Tonix Pharmaceuticals
investor.relations@tonixpharma.com
…
-
China NMPA approves Astellas Pharma's Padcev in combination with Keytruda to treat advanced bladder cancer
09 Jan 2025 04:00 GMT
… PD-1) or programmed death-ligand 1 (PD-L1) inhibitors … efficacy, safety, and pharmacokinetic performance of enfortumab vedotin … cell carcinoma.
Astellas and Pfizer have a clinical collaboration … combination of Astellas’ and Pfizer’s Padcev (enfortumab vedotin) …
-
Pfizer exits Sangamo pact; Roche, Ideaya strike ADC deals
03 Jan 2025 00:41 GMT
… partnering with another company. Pfizer has steadily retreated from … the protein delta-like ligand 3, or DLL3, and … Administration has approved Hikma Pharmaceuticals’ generic version of Novo … its 2017 launch. Teva Pharmaceutical launched an authorized generic …
About
© 1995-2025